Alembic Pharmaceuticals has informed that the Company’s Formulation Facility located at Panelav has received Establishment Inspection Report (EIR) from US Food & Drug Administration (FDA) for the inspection carried out by them in March, 2016.
The above information is a part of company’s filings submitted to BSE.